GENE ONLINE|News &
Opinion
Blog

R&D
Astellas’ Non-Hormonal Drug for Hot Flashes Shows Promise in Two Phase 3 Trials
2021-02-24
Researchers Test Gene Augmentation Therapy in Patient-Derived Retinal Organoids to Find Eye Disease Cure
2021-02-23
Dermavant Sciences’ Psoriasis Drug Promises in Phase 3 Trials
2021-02-20
Lilly to Expand Foothold in the Billion-Dollar Autoimmune and Inflammatory Disease Market with this New Collaboration
2021-02-20
George Church’s New Startup Engineers AAV Vectors that Evades Host Immune Responses
2021-02-17
Sperm Cells Poison Competitors, Those with Optimal Mobility Controlling Protein Wins the Race to the Egg
2021-02-15
Texas Biopharma Inks $1.3 Billion Worth BMS Deal to Develop Engineered Toxin Bodies
2021-02-14
Pacific Biosciences Secures 900 Million Investment to Advance Gene Sequencing
2021-02-13
R&D
AbbVie Signs Off-the-Shelf CAR-T Therapy Pact with Jennifer Doudna’s Caribou Biosciences
2021-02-11
Taiwan’s TTY Biopharm Pushes for Clinical Trials of its Complex Cancer Generic Drugs in Europe
2021-02-10
AZ’s Immune Checkpoint Inhibitor Flunks Head and Neck Cancer Trial
2021-02-10
Forxiga Gains Approval in China for Multiple Cardio-Related Diseases
2021-02-07
Gilead Aspires to Prolong Leadership in HIV Market, Launches Therapeutic Vaccine Quest with Gritstone
2021-02-03
CRISPR-Based Screening Implicates Mitochondrial Phosphatase Gene in Hypoxic Survival of Liver Cancer Cells
2021-02-03
Scientists Track Cancer cells’ Family Tree via CRISPR to Better Understand Metastasis
2021-01-25
1 18 19 20 21 22 35
LATEST
Biotech in Beauty: Engineered Skin Bacteria Designed To Treat Acne
2024-05-10
Revolutionizing Treatment: ASGCT’s Clinical Trials Spotlight on Immunotherapy, Cancer Vaccines, and Auditory Diseases
2024-05-09
Advancing Health: ASGCT’s Clinical Trials Spotlight on Cell Therapy and Cell-Based Gene Therapy
2024-05-09
Infinitopes’ Article in Peer-Reviewed Journal Seeks to Unlock the Potential of Cancer Vaccines
2024-05-09
Profluent Achieves Human Genome Editing Milestone Using OpenCRISPR-1: The First AI-Generated, Open-Source Gene Editor
2024-05-08
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
EVENT
Scroll to Top